Oncology Resource Center
Click on the subcategory below to find drug monographs for that particular area.
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
Patients with metastatic colorectal cancer that started on the left side may be more likely to survive than those whose disease originated on the right side.
U.S. recommendations against the prostate-specific antigen (PSA) test for prostate cancer might have prompted a small but measurable increase in the number of higher-risk cases diagnosed recently, according to a new study.
Suicide is a public health concern for patients with genitourinary cancer, especially bladder cancer, according to a new study.
Eisai announced results from a Phase 3 trial investigating the use of eribulin vs. dacarbazine in patients with advanced soft tissue sarcomas.
The first genetic variation linked to increased risk and severity of peripheral neuropathy following treatment with a common chemotherapy drug has been identified, according to scientists at St. Jude Children's Research Hospital.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Featured courses from myCME
This activity is designed to change health provider attitudes on chronic pain and willingness to ...
Breast lumps - Red flag symptoms
Clinical review – Multiple myeloma